- ASX200 is trading 1.2% lower today at 6933.5.
- Splitit sinks on disappointing first quarter results.
- 40-year-old man develops blood clots after Pfizer COVID-19 vaccine.
The tech sector is plummeting today driven by a near 17% loss for Nuix to an all-time low share price. The loss comes on the back of the data analytics group confirming it will not meet the business forecasts set out in its IPO documents on December 4, 2020.
The Australian market is sharply lower today, down 1.2% at 6933.5 at 1:30pm AEST amid a broad selloff especially in Energy and tech stocks, as all sectors trade in the red. The Materials, Mining and Resources sectors are also charging lower.
Australian retail sales added 1.4% for March indicating Australian?s were happy to splash some cash in retail spending despite JobKeeper ending in late March.
Bitcoin continues to climb this afternoon up 2.66% at US$55,783.69 at 1:30pm AEST.
BNPL provider Splitit is taking a hit on the ASX today after releasing disappointing first quarter results. Splitit sustained a 5% decline in quarter-on-quarter Merchant Sales Volume to US$82m, down from US$86.3m in Q4. The company also fell well short of competitors Zip Co and Afterpay who both topped US$1bn for the quarter.
Making headlines, a 40-year-old Australian man is in hospital with blood clots after receiving the Pfizer coronavirus vaccine three days ago. The news comes after three Australians were diagnosed with blood clots following receipt of the AstraZeneca vaccine.
Apple unveiled its latest products overnight at its ?Spring Loaded? event, including the highly anticipated Air Tags and a new podcast subscription service to compete with Spotify.